Cent Eur J Public Health 2004, 12(Supplement):S41-S44

Effects of Kojic Acid on Oxidative Damage and on Iron and Trace Element Level in Iron-overloaded Mice and Rats

Kotyzová D.1, Eybl V.1, Koutenský J.1, Brtko J.2, Glattre E.3
1 Department of Pharmacology and Toxicology, Charles University in Prague, Faculty of Medicine in Plzeň, Czech Republic
2 Institute of Experimental Endocrinology, Slovak Academy of Sciences, Bratislava, Slovak Republic
3 Cancer Registry of Norway, Oslo, Norway

Since members of hydroxypyrone series posses iron chelating properties, kojic acid (KA), 5-hydroxy-2- (hydroxymethyl)-4H-pyran-one, a fungal metabolite of natural origin, has been suggested to might play a role in iron-overload diseases and in oxidative stress conditions involving transition metal. In our experiments in vivo models of iron-overload were used to study iron-chelating properties of KA and its effect on oxidative damage in mice and rats. The treatment of iron-preloaded rats (25 mg Fe.kg-1 b.w., i.p., daily for five days) with 0.5% KA in drinking water for four weeks did not lower the iron concentration accumulated in the liver, neither diminished the induced hepatic lipid peroxidation in iron-loaded rats. The GSH level decreased in KA-treated group. Similarly, in iron-loaded mice model experiment, the following oral treatment with KA (100 mg.kg-1) daily for 7 days did not decrease the level of Fe accumulated in the liver and the lipid peroxidation even enhanced after KA treatment. Though in our experiments in vivo the ability of kojic acid to affect iron kinetics in the organism could not be proved, kojic acid as a molecule of natural origin may serve as a template for the preparation of new biologically active derivatives possessing capability of chelating iron.

Keywords: kojic acid, chelator, iron accumulation, oxidative damage, trace elements

Published: March 1, 2004  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kotyzová D, Eybl V, Koutenský J, Brtko J, Glattre E. Effects of Kojic Acid on Oxidative Damage and on Iron and Trace Element Level in Iron-overloaded Mice and Rats. Cent Eur J Public Health. 2004;12(Supplement):S41-44. PubMed PMID: 15141975.
Download citation

References

  1. Burdock GA, Soni MG, Carabin IG: Evaluation of health aspects of kojic acid in food. Regul Toxicol Pharmacol 2001; 33: 80 -101. Go to original source... Go to PubMed...
  2. UherM, Chalabala M, Čižmárik J: Potential use of the kojic acid and its derivatives in treatment. Čes Slov Farm 2000; 49: 288-298. (In Czech.)
  3. Tamura T, Mitsumori K, Onodera H, Fujimoto N, Yasuhara K, Takegawa K, Takahashi M: Inhibition of thyroid iodine uptake and organification in rats treated with kojic acid. Toxicol Sci 1999; 47: 170-175. Go to original source...
  4. Tamura T, Mitsumori K, Onodera H, Fujimoto N,Yasuhara K, Takegawa K, Takagi H, Hirose M: Dose-treshold for thyroid tumor-promoting effects of orally administered kojic acid in rats after initiation with N-bis(2-hydroxypropyl) nitrosamin. J Toxicol Sci 2001; 26: 85-94. Go to original source... Go to PubMed...
  5. Fujimoto N, Onodera H, Mitsumori K, Tamura T, Maruyama S, Ito A: Changes in thyroid function during development of thyroid hyperplasia induced by kojic acid in F344 rats. Carcinogenesis 1999; 20: 1567-1571 Go to original source...
  6. Molenda JJ, Basinger MA, Hanusa TP, Jones MM: Synthesis and iron (III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid. J Inorg Biochem 1994; 55: 131-46. Go to original source... Go to PubMed...
  7. Novotný L, Rauko P, Abdel-Hamid M, Vachalková A: Kojic acid - a new leading molecule for a preparation of compounds with an antineoplastic potential. Neoplasma 1999; 46: 89-92. Go to PubMed...
  8. Niwa Y, Akamatsu H: Kojic acid scavenges free radicals while potentiating leukocyte function including free radical generation. Inflammation 1991; 5: 303-315. S44 Go to original source...
  9. Mitani H, Koshiishi I, Sumita T, Imanari T: Prevention of the photodamage in the hairless mouse dorsal skin by kojic acid as an iron chelator. Eur J Pharmacol 2001; 411: 169-174. Go to original source...
  10. Uichima M, Mihara M: Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Analyt Biochem 1978; 86: 217-278. Go to original source...
  11. Sedlak J, Lindsay RH: Estimation of total, proteinbound and nonprotein sulfhydryl groups in tissue with Ellman's reagent.Analyt Biochem 1968; 25: 192-205. Go to original source... Go to PubMed...
  12. GünzlerVA, Kremers H, Flohé L:An improved coupled test procedure for glutathione peroxidase (EC 1.11.1.9.) in blood. Z Klin Chem Biochem 1974; 12: 444-448. Go to original source...
  13. Aebi H: Catalase. In: Methods of EnzymaticAnalysis, vol 2, 1972 (H.U. Bergmeyer, ed.), New York & London, Academic Press, 673-684 Go to original source...
  14. Katoh S, Toyama J, Kodama I, Kamiya K,Akita T,Abe T: Protective action of iron-chelating agents (catechol, mimosine, deferoxamine, and kojic acid) against ischemia-reperfusion injury of isolated neonatal rabbit hearts. Eur Surg Res 1992; 24: 349-355. Go to original source... Go to PubMed...
  15. van der KraaijAM, van Eijk HG, Koster JF: Prevention of postischemic cardiac injury by the orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol. Circulation 1989; 80: 158-164. Go to original source...